Sobi - Swedish Orphan Biovitrum AB (publ) · 18 hours ago
Finance Internship (Hybrid)
Waltham, MA, USA
Internship
Hybrid
Intern
$25/hr - $30/hrSobi is a global biopharmaceutical company dedicated to improving the lives of people with rare diseases. The Finance Internship offers a unique opportunity to support the revenue team by documenting key processes, automating workflows, and contributing to analytical projects within a collaborative team environment.
BiotechnologyGeneticsMedicalPharmaceutical
No H1B
Responsibilities
Support the revenue team by documenting and standardizing key processes including SOPs, process flows, and Gross to Net accrual methodologies
Work on automating manual workflows through various dashboard developments
Contribute to analytical projects such as lag, flux, and patient-level analysis
Update and refine hindsight models
Deadline-driven with a high level of organizational and planning skills
Strong Excel, analytical, problem-solving, and oral and written communication skills
Ability to work with large data sets and build automated processes
Good understanding of financial concepts
Ability to work well in teams, effectively manage projects, and present ideas clearly and concisely
Global mindset to grow in a diverse work environment
Other specific responsibilities will be dependent upon the needs of the mentor and qualifications/skillset of the candidate
Qualification
Required
Candidates must be currently enrolled at an accredited university
Must be authorized to work in the US without sponsorship (i.e., Sobi, Inc. will not sponsor interns)
Minimum GPA 3.0
Undergraduate student with at least 2 years of university studies before internship
Return to university for at least one semester post-internship
Sobi, Inc. does not provide student housing or housing stipends and is not a salaried position
Benefits
Competitive compensation for your work
Generous time off policy
Opportunity to broaden your horizons by attending popular conferences
Emphasis on work/life balance
Collaborative and team-oriented environment
Making a positive impact to help ultra-rare disease patients who are in need of life saving treatments
Company
Sobi - Swedish Orphan Biovitrum AB (publ)
Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases.
Founded in 1988
1001-5000 employees
Funding
Current Stage
Public CompanyTotal Funding
$825.99M2024-05-08Post Ipo Debt· $274.92M
2023-08-22Post Ipo Equity· $551.07M
2006-09-15IPO
Leadership Team
Guido Oelkers
Chief Executive Officer
Recent News
PR Newswire
2026-01-16
News Powered by Cision
2026-01-16
Company data provided by crunchbase